DaVita Aktie
| 129,19USD | 1,13USD | 0,88% |
WKN: 897914 / ISIN: US23918K1088
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 67 000 | 69 000 | 70 000 | 70 000 | 76 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,17 | 0,17 | 0,17 | 0,17 | 0,17 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 3 149 | 3 168 | 3 155 | 3 138 | 3 746 |
| Summe Anlagevermögen | 14 613 | 14 703 | 14 524 | 14 482 | 14 226 |
| Summe Aktiva | 17 762 | 17 871 | 17 680 | 17 619 | 17 972 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 14 865 | 15 500 | 15 455 | 14 876 | 15 881 |
| Summe Eigenkapital | 2 897 | 2 371 | 2 225 | 2 743 | 2 091 |
| Summe Passiva | 17 762 | 17 871 | 17 680 | 17 619 | 17 972 |
Adresse
| 2000 16th Street, 80202-7198 Denver | |
| Telefon | +1 (720) 631-2100 |
| Internet | http://www.davita.com |
Management
|
Adam H. Schechter
Independent Director |
|
Alan Cullop
Chief Information Officer |
|
Andrew Mohraz
Associate General Counsel & Head-Investigations |
|
Barbara Jean Desoer
Independent Non-Executive Director |
|
Bruce E. Ware
Vice President |
|
Christopher M. Berry
Chief Accounting Officer |
|
David P. Maughan
Chief Operating Officer |
|
Dennis W. Pullin
Independent Director |
|
Gregory J. Moore
Independent Director |
|
James O. Hearty
Chief Compliance Officer |
|
Jason M. Hollar
Independent Director |
|
Javier J. Rodriguez
Chief Executive Officer & Director |
|
Jeffrey A. Giullian
Chief Medical Officer-Kidney Care |
|
Jeffrey Wagner
Senior Vice President |
|
Jessica Hergenreter
Chief People Officer |
|
Joel Ackerman
Chief Financial Officer & Treasurer |
|
Kathleen Alyce Waters
Chief Legal & Public Affairs Officer |
|
Madhu Narasimhan
Chief Information Officer |
|
Mahesh Krishnan
Group Vice President-Growth |
|
Michael D. Staffieri
Chief Operating Officer-Emeritus |
|
Nic Eliason
Investor Relations Contact |
|
Pamela M. Arway
Chairman |
|
Phyllis R. Yale
Independent Non-Executive Director |
|
Samantha A. Caldwell
Secretary |
|
Tina Livaudais
Chief Nursing Officer |
|
Wendy Lee Schoppert
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.